GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors

British Journal of Haematology

Volumn 154, Issue 5, 2011, Pages 564-568

  Latagliata, Roberto ^a   Breccia, Massimo ^a   Fazi, Paola ^b   Vignetti, Marco ^b   di Raimondo, Francesco ^c   Sborgia, Marco ^d   Vincelli, Donatella ^e   Candoni, Anna ^f   Salvi, Flavia ^g   Rupoli, Serena ^h   Martinelli, Giovanni ⁱ   Kropp, Maria Grazia ^j   Tonso, Anna ^k   Venditti, Adriano ^l   Melillo, Lorella ^m   Cimino, Giuseppe ^a   Petti, Maria Concetta ⁿ   Avvisati, Giuseppe ^o   Lo Coco, Francesco ^l,p   Mandelli, Franco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Centro Calcolo GIMEMA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Pescara UO Ematologia Clinica   (Italy)

^e BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^f UNIVERSITY OF UDINE   (Italy)

^g C Arrigo Children's Hospital   (Italy)

^h Universit Politecnica Marche   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

^j PUGLIESE CIACCIO HOSPITAL   (Italy)

^k OSPEDALE DEGLI INFERMI   (Italy)

^l UNIVERSITY OF ROME TOR VERGATA   (Italy)

^m CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁿ REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^o UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^p IRCCS FONDAZIONE SANTA LUCIA   (Italy)

more..

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Consolidation therapy; Elderly acute promyelocytic leukaemia

Indexed keywords

CYTARABINE; IDARUBICIN; RETINOIC ACID;

ADULT; AGED; ARTICLE; BLEEDING; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; ELDERLY CARE; FEMALE; GENE; HEALTH CARE ORGANIZATION; HEART ARRHYTHMIA; HUMAN; INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PML GENE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; PYREXIA IDIOPATHICA; RARA GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; HEMORRHAGE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRETINOIN;

EID: 80051593309     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08593.x     Document Type: Article

References (17)

1. Ades, L., Chevret, S., De Botton, S., Thomas, X., Dombret, H., Beve, B., Sanz, M., Guerci, A., Miguel, J.S., de la Serna, J., Garo, C., Stoppa, A.M., Reman, O., Stamatoulas, A., Fey, M., Cahn, J.Y., Sotto, J.J., Bourhis, J.H., Parry, A., Chomienne, C., Degos, L., Fenaux, P. & for the European APL Group. (2005) Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience. leukemia, 19, 230-233.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Annals of Internal Medicine, 103, 620-625.
3. Chomczynsky, P. & Sacchi, N. (1987) Single step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Annals of Biochemistry, 162, 156-159.
4. Cox, D.R. (1972) Regression models and life-tables. Journal of the Royal Statistical Society. Series B, 34, 187-220.
5. Diverio, D., Riccioni, R., Pistilli, A., Buffolino, S., Avvisati, G., Mandelli, F. & Lo Coco, F. (1996) Improved rapid detection of the PML/RARalpha fusion gene in acute promyelocytic leukemia. leukemia, 10, 1214-1216.
6. Gooley, T.A., Leisenring, W., Crowley, J. & Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695-706.
7. Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 1141-1154.
8. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of American Statistics Association, 53, 457-481.
9. Lo Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G. & Mandelli, F. (1999) Therapy of molecular relapse in acute promyelocytic leukemia. Blood, 94, 2225-2229.
10. Lo-Coco, F., Cimino, G., Breccia, M., Noguera, N.I., Diverio, D., Finolezzi, E., Pogliani, E.M., Di Bona, E., Micalizzi, C., Kropp, M., Venditti, A., Tafuri, A. & Mandelli, F. (2004) Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia. Blood, 104, 1995-1999.
11. Mandelli, F., Diverio, D., Avvisati, G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A. & Lo Coco, F. (1997) Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood, 90, 1014-1021.
12. Mandelli, F., Latagliata, R., Avvisati, G., Fazi, P., Rodeghiero, F., Leoni, F., Gobbi, M., Nobile, F., Gallo, E., Fanin, R., Amadori, S., Vignetti, M., Fioritoni, G., Ferrara, F., Peta, A., Giustolisi, R., Broccia, G., Petti, M.C. & Lo-Coco, F. (2003) Treatment of elderly patients (> or =60years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. Leukemia, 17, 1085-1090.
13. Mantel, N. (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Report, 50, 163-170.
14. Sanz, M.A., Lo Coco, F., Martin, G., Avvisati, G., Rayon, C., Barbui, T., Diaz-Mediavilla, J., Fioritoni, G., Gonzales, J.D., Liso, V., Esteve, J., Ferrara, F., Bolufer, P., Bernasconi, C., Gonzales, M., Rodeghiero, F., Colomer, D., Petti, M.C., Ribera, J.M. & Mandelli, F. (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood, 96, 1247-1253.
15. Sanz, M.A., Vellenga, E., Rayón, C., Díaz-Mediavilla, J., Rivas, C., Amutio, E., Arias, J., Debén, G., Novo, A., Bergua, J., de la Serna, J., Bueno, J., Negri, S., Beltrán de Heredia, J.M. & Martín, G. (2004) All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood, 104, 3490-3493.
16. Sanz, M.A., Grimwade, D., Tallman, M.S., Lowenberg, B., Fenaux, P., Estey, E.H., Naoe, T., Lengfelder, E., Büchner, T., Döhner, H., Burnett, A.K. & Lo-Coco, F. (2009) Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemianet. Blood, 113, 1875-1891.
17. Tsimberidou, A.M., Kantarjian, H., Keating, M.J. & Estey, E. (2006) Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide? Leukemia and Lymphoma, 47, 2282-2288.